A feasibility study of transaxillary TAVI with the lotus valve.
Sagar N DoshiSudhakar GeorgeChun Shing KwokAnthony MecheryMamas MamasPeter F LudmanJonathan N TownendMoninder BhabraPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2017)
Ten patients aged 75 years (69-83) underwent attempted TAVI with the Lotus via axillary access. Device success was 100%. In-hospital and 30-day mortality was zero. There were no neurological events, no major vascular complications and no myocardial infarctions. Four of 10 patients required a pacemaker post-TAVI. No patient was left with moderate or greater aortic regurgitation. Median length of stay was 3 days CONCLUSIONS: TAVI with the Lotus valve is feasible via the axillary artery and appears safe in our small cohort of patients.
Keyphrases
- aortic valve
- end stage renal disease
- aortic stenosis
- ejection fraction
- newly diagnosed
- chronic kidney disease
- transcatheter aortic valve implantation
- transcatheter aortic valve replacement
- peritoneal dialysis
- healthcare
- prognostic factors
- type diabetes
- left ventricular
- heart failure
- risk factors
- neoadjuvant chemotherapy
- mitral valve
- ultrasound guided
- patient reported